Clinical Trial Update: SNAP 25 Gene Study

View source ↗

Summary

A clinical trial evaluating the SNAP-25 gene in Attention-Deficit/Hyperactivity Disorder sponsored by the University of British Columbia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: University of British Columbia | Conditions: Attention-Deficit/Hyperactivity Disorder | Status: TERMINATED